Home Headlines World 16 vaccines against Covid-19 enter clinical evaluation stage, 125 candidates in preclinical...

16 vaccines against Covid-19 enter clinical evaluation stage, 125 candidates in preclinical evaluation: WHO’s draft landscape – world news


With nearly 10 million Covid-19 patients across the globe and over 4.8 coronavirus fatalities, the need for a Covid-19 antidote becomes more urgent by the day.

The University of Oxford and AstraZeneca Plc.’s experimental vaccine, ChAdOx1-S, has become the first to enter the final stages of clinical trials against the coronavirus disease.

But Oxford and AstraZeneca’s collaborative initiative is not the only one in the race to arrive at a potential Covid-19 vaccine.

According to the World Health Organisation’s draft landscape of Covid-19 vaccines, there were 10 candidates in the advanced clinical trials and 115 in preclinical evaluation stages on June 12. On June 22, 13 experimental vaccines were there in clinical trials and another 129 in the preclinical evaluation stage. The latest WHO draft notifies 16 experimental vaccines to be in clinical trials and another 125 in the preclinical evaluation stage as of June 24.

CanSino Biological Inc./Beijing Institute of Biotechnology; Moderna/NIAID; Wuhan Institute of Biological Products/Sinopharm; Beijing Institute of Biological Products/Sinopharm; Sinovac; Novavax; BioNTech/Fosun Pharma/Pfizer; Institute of Medical Biology, Chinese Academy of Medical Sciences; Inovio Pharmaceuticals; Genexine Consortium; Gamaleya Research Institute; Clover Biopharmaceuticals Inc./GSK/Dynavax; Anhui Zhifei Longcom Biopharmaceutical/Institute of Microbiology, Chinese Academy of Sciences; Imperial College London and Curevac are 15 other contenders who have their experimental vaccines in the clinical trials phase, WHO’s latest draft landscape states.

Spearheading the effort to formulate a Covid-19 vaccine are US-based Moderna Inc. and China’s Sinovac Biotech – both will enter the final stage of trials next month.

Beijing-based China National Biotec Group Co. is the latest to receive regulatory approval to conduct phase 3 trials of its Covid-19 vaccines in the United Arab Emirates on Tuesday.

Indian companies are also partnering to develop vaccine candidates that are currently in the preclinical trial stages.Serum Institute of India (SII) has partnerships with US-biotech firm Codagenix, Austria’s Themis Bioscience and Oxford-AstraZeneca.

Bharat Biotech in Hyderabad is working on three vaccine candidates. Delhi-based Panacea Biotec is partnering with Refana Inc. in the US to develop an inactivated whole virus vaccine. Zydus Cadila in Ahmedabad and Hyderabad-based India Immunologicals have also formed partnerships to develop Covid-19 vaccines.

Stay tune

110FansLike
400FollowersFollow

Most Popular

US helps India, China protests; Decision within the US Congress

The USA has lauded India's aggression in opposition to China within the wake of the Line of Management (LoC) battle in Ladakh.

In 24 hours, 1,007 individuals died and 64,553 new circumstances had...

The variety of coronary coronary heart illness sufferers within the nation is growing quickly. Greater than 60,000 coronary coronary heart illness sufferers...

Terrorist assault in Jammu and Kashmir, two policemen martyred; Search operation...

A police convoy has been attacked in Jammu and Kashmir. The assault happened within the Naugaon sector of Srinagar. Two policemen have...

Prashant Bhushan convicted of contempt of Supreme Courtroom, sentenced on August...

Senior lawyer Prashant Bhushan has been convicted by the Supreme Courtroom of contempt of courtroom. A photograph of Chief Justice Sharad Bobade...

Nishan-e-Pakistan award for separatist chief Syed Ali Shah Geelani in Jammu...

Former Hurriyat and separatist chief Syed Ali Shah Geelani has been honored by Pakistan on its Independence Day. On Friday, August 14,...

6 members of Mirza’s household together with BJP MLA contracted coronary...

Incumbent BJP MLA from Sangli-Miraj assembly constituency and former social justice minister Suresh Khade has contracted coronary heart disease.

One jawan martyred, one injured in Naxal firing in Gadchiroli

Gadchiroli: One policeman was killed and one other injured when Naxals opened fireplace on two jawans who had been on their option...

Swami was livid over the Air India sale supply to the...

Stated "If the deal goes forward, I'll file a felony criticism towards bigwigs within the authorities."